Jonathan Barratt, PhD, FRCP - 2025 Congress Highlights From Houston, Texas: Breaking Down the Data Driving Therapeutic Developments in IgA Nephropathy

Visit https://www.peervoice.com/KFX860 to view the entire programme with slides. After completing “Jonathan Barratt, PhD, FRCP - 2025 Congress Highlights From Houston, Texas: Breaking Down the Data Driving Therapeutic Developments in IgA Nephropathy”, participants will be able to: Recall recent efficacy and safety trial data on new and emerging therapies in IgA nephropathy (IgAN); and Assess recent therapeutic developments in the context of proposed KDIGO recommended treatment targets in the management of IgAN.

Listen